Patent · US Active

Nucleoside phosphoramidates

US8716262B2 · kind B2 · utility

49Cited by
219References
36Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 23, 2009
Grant dateMay 6, 2014
Priority date—
Expiry dateJul 8, 2030

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A nucleoside compound having activity against hepatitis C virus is disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.